BSE: 507715 | NSE: | Pharmaceuticals & Drugs |
Data is not available for this company.
No data found
No data found
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
No data to display
Return on Equity has declined versus last 3 years average to %
Standalone | Consolidated | |
---|---|---|
TTM EPS (₹) | - | - |
TTM Sales (₹ Cr.) | - | - |
BVPS (₹.) ⓘ | - | - |
Reserves (₹ Cr.) ⓘ | - | - |
P/BV ⓘ | - | - |
PE ⓘ | - | - |
From the Market | |
---|---|
52 Week Low / High (₹) | 0.00 / 0.00 |
All Time Low / High (₹) | 0.60 / 60.00 |
Market Cap (₹ Cr.) | - |
Equity (₹ Cr.) | - |
Face Value (₹) | - |
Industry PE ⓘ | - |
Ebers Pharmaceuticals was incorporated on October 05, 1978 as a Private Limited Company. It went into public on November 05, 1985.
The Company is engaged in manufacturing of Tablets, Capsules, Liquid Orals, Dry Syrups & oral Rehydration Salts for both exports & for domestic consumption.
Ebers Pharmaceuticals has established itself as a manufacturer of quality, pharmaceutical products & the Comp. has been receiving regular Loan Licence, work from reputed multinationals & Indian pharmaceutical companies like E. Merck, Boeringher, BDH, etc. The Comp. has also recently tied up with Geekay Exim Limited, an export house, is expected to increase production levels substantially.
It engaged services of M/s Klenzaids Aseptic Technologies Pvt. limited for setting up the Sterile Section.